Satudora Holdings Warns of Sharper Profit Drop Despite Steady Sales and Higher Dividend

SATUDORA HOLDINGS CO., LTD. ( (JP:3544) ) has shared an update.

Satudora Holdings reported consolidated net sales of ¥75.9 billion for the nine months to February 15, 2026, essentially flat year on year, while operating profit fell 27.7% to ¥932 million and profit attributable to owners of parent dropped 31.0% to ¥485 million, reflecting margin pressure despite stable revenue. Total assets rose to ¥50.4 billion and equity increased modestly, but the equity ratio edged down to 20.1%, indicating a slightly higher leverage profile.

The company kept its interim dividend at zero but plans a higher full-year dividend of ¥12 per share, up from ¥10 in the previous fiscal year, signaling continued shareholder returns despite weaker earnings. Management revised its full-year forecast, now expecting marginal sales growth to ¥100.5 billion but steep declines in operating profit and net income of 34.3% and 47.9%, respectively, underscoring a challenging profit environment for the regional drugstore operator and potential pressure on future profitability even as it maintains its market footprint.

The most recent analyst rating on (JP:3544) stock is a Hold with a Yen929.00 price target. To see the full list of analyst forecasts on SATUDORA HOLDINGS CO., LTD. stock, see the JP:3544 Stock Forecast page.

More about SATUDORA HOLDINGS CO., LTD.

Satudora Holdings Co., Ltd. is a Japan-based retailer operating mainly drugstores and related healthcare and daily goods outlets, listed on the Tokyo Stock Exchange and Sapporo Securities Exchange. The group focuses on regional consumers, offering pharmaceuticals, daily necessities, and lifestyle products, positioning itself as a convenience and health-focused retailer in its core markets.

Average Trading Volume: 13,603

Technical Sentiment Signal: Buy

Current Market Cap: Yen11.54B

See more insights into 3544 stock on TipRanks’ Stock Analysis page.